Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy.

ECG screening in athletes: optional or mandatory? Neth Heart J (2015) 0.85

Diagnosis, pathophysiology, and management of exercise-induced arrhythmias. Nat Rev Cardiol (2016) 0.83

Relationship Between Arrhythmogenic Right Ventricular Cardiomyopathy and Brugada Syndrome: New Insights From Molecular Biology and Clinical Implications. Circ Arrhythm Electrophysiol (2016) 0.78

Accelerated cardiac remodeling in desmoplakin transgenic mice in response to endurance exercise is associated with perturbed Wnt/β-catenin signaling. Am J Physiol Heart Circ Physiol (2015) 0.76

Arrhythmogenic right ventricular cardiomyopathy and sports activity. Eur Heart J (2015) 0.76

Prevention is better than cure: the new ESC Guidelines. Eur Heart J (2016) 0.75

Nature and Nurture in Arrhythmogenic Right Ventricular Cardiomyopathy - A Clinical Perspective. Arrhythm Electrophysiol Rev (2015) 0.75

Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries. Scand Cardiovasc J (2015) 0.75

A classic case of arrhythmogenic right ventricular cardiomyopathy (ARVC) and literature review. J Community Hosp Intern Med Perspect (2017) 0.75

Exercise Dose in Clinical Practice. Circulation (2016) 0.75

Arrhythmogenic cardiomyopathy. Orphanet J Rare Dis (2016) 0.75

Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes. Arrhythm Electrophysiol Rev (2016) 0.75

Precision medicine approach to genetic cardiomyopathy. Herz (2017) 0.75

Medico-legal perspectives on sudden cardiac death in young athletes. Int J Legal Med (2016) 0.75

Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J (1994) 7.54

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71

Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med (1988) 5.22

Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol (2003) 3.52

Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J (2011) 2.80

Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation (2006) 2.76

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J (2005) 2.29

Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation (2003) 2.13

High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J (2003) 2.05

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation (2004) 1.82

Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart (2010) 1.82

Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail (2014) 1.73

Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol (2013) 1.66

Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (2010) 1.62

Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation (2006) 1.48

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation (2003) 1.32

Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil (2006) 1.11

Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J Am Heart Assoc (2014) 1.03

Burden of sudden cardiac death in persons aged 1 to 49 years: nationwide study in Denmark. Circ Arrhythm Electrophysiol (2014) 1.01

Sudden cardiac death in children (1-18 years): symptoms and causes of death in a nationwide setting. Eur Heart J (2013) 0.96

Arrhythmogenic right ventricular cardiomyopathy: a challenging disease of the intercalated disc. Circulation (2013) 0.84

The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling. Eur Heart J (2014) 1.39

Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J (2016) 0.75